Palisade Bio (PALI) Other Non Operating Income (2010 - 2026)
Palisade Bio (PALI) reported Other Non Operating Income of $1.1 million for Q1 2026, up 1318.52% year-over-year from $81000.0 in Q1 2025, and up 6.0% quarter-over-quarter from $1.1 million in Q4 2025.
Palisade Bio (PALI) Other Non Operating Income (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 16 years of Other Non Operating Income data on file, last reported at $1.1 million in Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $1.1 million, up 1318.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 541.14% YoY), and the FY2025 annual result was $1.3 million, up 196.77% from the prior year.
- Other Non Operating Income climbed to $1.1 million in Q1 2026 per PALI's latest filing, from $1.1 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $1.2 million in Q2 2022 and troughed at $41000.0 in Q4 2024.
- A 5-year average of $366823.5 and a median of $187000.0 in 2023 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2025: Other Non Operating Income plunged 96.66% in 2022, then jumped 2543.9% in 2025.
- A 5-year view of Other Non Operating Income shows it stood at $131000.0 in 2022, then surged by 42.75% to $187000.0 in 2023, then tumbled by 78.07% to $41000.0 in 2024, then jumped by 2543.9% to $1.1 million in 2025, then climbed by 6.0% to $1.1 million in 2026.
- Business Quant data shows PALI's Other Non Operating Income at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $59000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | 59,000.00 |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | 81,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 133,000.00 |
| Mar 31, 2024 | 147,000.00 |
| Dec 31, 2023 | 187,000.00 |
| Sep 30, 2023 | 190,000.00 |
| Jun 30, 2023 | 219,000.00 |
| Mar 31, 2023 | 189,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Sep 30, 2022 | 426,000.00 |
| Jun 30, 2022 | 1.23 Mn |
| Mar 31, 2022 | 794,000.00 |
| Sep 30, 2021 | 12.76 Mn |
| Jun 30, 2021 | 5.13 Mn |
| Sep 30, 2020 | 1,000.00 |